Trending Keyword "breast cancer"
“Breast cancer” is trending because there’s been a steady stream of new clinical updates that affect both screening and treatment decisions. In particular, the FDA recently approved Enhertu (fam-trastuzumab deruxtecan) for additional HER2-positive early breast cancer indications (including neoadjuvant and adjuvant settings), which tends to spike searches from patients, caregivers, and clinicians. (fda.gov) At the same time, guideline and risk-assessment conversations are heating up-e.g., NCCN screening guidance updates discussed in 2026 include starting screening earlier for higher-risk women (as identified by risk approaches, including AI risk identification). (ascoai.org) Finally, insurers and healthcare systems are increasingly focused on how screening is measured and covered, including CMS refinements to breast cancer screening-related quality metrics for coming rating years. (cms.gov)
Industries
Hospitals and health systems are directly impacted by new FDA approvals for early breast cancer treatment (e.g., updated HER2-positive indications), which changes care pathways, tumor-board discussions, and patient counseling.
Pharmaceuticals are a strong fit because recent FDA actions and late-stage development updates for breast-cancer drugs (including HER2-directed therapies and other agents moving through the regulatory process) drive high-intent searches.
Diagnostics is closely connected because breast cancer search interest often rises around screening/risk tools—especially updates involving AI-assisted mammography risk assessment and updated screening recommendations for higher-risk groups.
Health insurance is relevant because coverage and reimbursement decisions for screening and emerging screening technologies/approaches can depend on guideline alignment and CMS quality measure changes.
Public health is directly tied to breast cancer prevention efforts—search trends often climb when screening guidance is updated and when healthcare performance/measurement frameworks emphasize earlier or improved screening access.
Keyword intents
“Breast cancer” is primarily an informational topic query (what it is, symptoms, diagnosis, treatment, prognosis).
The query centers on a serious health condition, often reflecting concern about diagnosis, symptoms, or risk.
Medical guidance and treatment options evolve, so some users may want up-to-date information, but the query itself is not explicitly time-sensitive.
Some users may be trying to reach well-known health organizations/resources (e.g., major cancer charities), but it’s not directly brand/site-specific.
This is a broad head term; it doesn’t include specific modifiers (stage, symptoms, risk factors, treatment type).
Seriousness may imply concern, but there’s no explicit urgency term like “now,” “today,” or emergency wording.
The keyword is general and doesn’t reference a city/region or “near me,” though some users may be seeking local care/services.
No buy/subscribe/booking language (e.g., “treatment,” “clinic near me,” “donate”)—mostly research or health information.
Breast cancer awareness is associated with October, but the keyword alone doesn’t signal awareness-month intent.
Most intent is learning/medical understanding rather than “how to” self-administer actions; wording doesn’t imply DIY steps.
No “vs,” “compare,” or alternatives phrasing.
No brand name, organization, or product/company identifier in the query.
Not tied to a particular treatment/product/model/SKU.
No pricing/value language (e.g., cost, insurance, free, cheap).
Keyword ideas
Longtail
None stored yet.
Synonyms
None stored yet.
Antonyms
None stored yet.